-
Founded in:
1988-04-05 -
Country:
China -
Address:
No. 505, Jinren Road, Jinshan District, Shanghai -
Tax NO.:
91310116134213626T -
Registered Funds:
75 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sodium lactate |
It can correct metabolic acidosis. When hyperkalemia is accompanied by acidosis, it can allow potassium ions to enter cells from the blood and extracellular fluid.
More
It can correct metabolic acidosis. When hyperkalemia is accompanied by acidosis, it can allow potassium ions to enter cells from the blood and extracellular fluid. |
3.10g | 312-85-6 | 0 |
| Sodium chloride |
Under normal circumstances, human blood also contains a small amount of lactic acid, which is mainly produced by glucose or glycogenolysis, and comes from muscles, skin, brain and cells. After lactic acid is produced, it may be converted into glycogen or acetic acid, or enter the tricarboxylic acid cycle and be decomposed into water and carbon dioxide. Therefore, the final metabolite of sodium lactate is sodium bicarbonate, which can correct metabolic acidosis. When hyperkalemia is accompanied by acidosis, sodium lactate can correct acidosis and allow potassium ions to enter cells from blood and extracellular fluid. The main organs that degrade lactic acid are liver and kidney. When lactic acid metabolism in the body is abnormal or impaired, the therapeutic effect is poor.
More
Under normal circumstances, human blood also contains a small amount of lactic acid, which is mainly produced by glucose or glycogenolysis, and comes from muscles, skin, brain and cells. After lactic acid is produced, it may be converted into glycogen or acetic acid, or enter the tricarboxylic acid cycle and be decomposed into water and carbon dioxide. Therefore, the final metabolite of sodium lactate is sodium bicarbonate, which can correct metabolic acidosis. When hyperkalemia is accompanied by acidosis, sodium lactate can correct acidosis and allow potassium ions to enter cells from blood and extracellular fluid. The main organs that degrade lactic acid are liver and kidney. When lactic acid metabolism in the body is abnormal or impaired, the therapeutic effect is poor. |
6.00g | 7647-14-5 | 43 |
| Potassium chloride |
Hyperkalemia with acidosis can cause potassium ions to enter cells from the blood and extracellular fluid.
More
Hyperkalemia with acidosis can cause potassium ions to enter cells from the blood and extracellular fluid. |
0.30g | 7447-40-7 | 38 |
| Calcium chloride |
Under normal circumstances, human blood also contains a small amount of lactic acid, which is mainly produced by glucose or glycogenolysis, and comes from muscles, skin, brain and cells. After lactic acid is produced, it may be converted into glycogen or acetic acid, or enter the tricarboxylic acid cycle and be decomposed into water and carbon dioxide. Therefore, the final metabolite of sodium lactate is sodium bicarbonate, which can correct metabolic acidosis. When hyperkalemia is accompanied by acidosis, sodium lactate can correct acidosis and allow potassium ions to enter cells from blood and extracellular fluid. The main organs that degrade lactic acid are liver and kidney. When lactic acid metabolism in the body is abnormal or impaired, the therapeutic effect is poor.
More
Under normal circumstances, human blood also contains a small amount of lactic acid, which is mainly produced by glucose or glycogenolysis, and comes from muscles, skin, brain and cells. After lactic acid is produced, it may be converted into glycogen or acetic acid, or enter the tricarboxylic acid cycle and be decomposed into water and carbon dioxide. Therefore, the final metabolite of sodium lactate is sodium bicarbonate, which can correct metabolic acidosis. When hyperkalemia is accompanied by acidosis, sodium lactate can correct acidosis and allow potassium ions to enter cells from blood and extracellular fluid. The main organs that degrade lactic acid are liver and kidney. When lactic acid metabolism in the body is abnormal or impaired, the therapeutic effect is poor. |
0.2g | 10043-52-4 | 27 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Children's compound amino acid (18AA-Ⅱ) |
Provides a variety of essential amino acids for the human body to supplement children's protein needs and promote metabolism
More
Provides a variety of essential amino acids for the human body to supplement children's protein needs and promote metabolism |
0 | ||
| Children's amino acid compound |
Provides essential and non-essential amino acids to meet children's physiological needs and promote protein synthesis
More
Provides essential and non-essential amino acids to meet children's physiological needs and promote protein synthesis |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Children's amino acid compound |
Provides essential and non-essential amino acids to supplement the protein needs of children, promote growth and development, and maintain normal physiological functions
More
Provides essential and non-essential amino acids to supplement the protein needs of children, promote growth and development, and maintain normal physiological functions |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Dextran |
Expand blood volume and improve microcirculation
More
Expand blood volume and improve microcirculation |
60mg | 9004-54-0 | 16 |
| L-tert-Leucine |
Supplement nutrients and nitrogen sources to support protein synthesis
More
Supplement nutrients and nitrogen sources to support protein synthesis |
2.72mg | 20859-02-3 | 0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ozagrel sodium |
|
189224-26-8 | 10 | |
| GLUCOSE |
|
58367-01-4 | 14 |